Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2023 | 07-2023 | 04-2023 | 01-2023 | 10-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -393 | -3,183 | -4,316 | -4,190 | -3,426 |
| Accounts payable and accrued liabilities | -2 | 590 | -243 | 75 | 656 |
| Other Working Capital | 76 | 631 | -297 | -129 | 444 |
| Other Operating Activity | -1,322 | 2,306 | 1,062 | 739 | -638 |
| Operating Cash Flow | $-1,641 | $343 | $-3,794 | $-3,505 | $-2,964 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 0 | 1 | 1 | 1 |
| Common Stock Repurchased | -26,622 | -26,457 | -13,561 | -9,254 | -5,476 |
| Other Financing Activity | 33,650 | 32,736 | 0 | 0 | 0 |
| Financing Cash Flow | $7,028 | $6,279 | $-13,560 | $-9,253 | $-5,475 |
| Exchange Rate Effect | -1 | 1 | -7 | -2 | 1 |
| Beginning Cash Position | 68,040 | 68,040 | 85,401 | 85,401 | 85,401 |
| End Cash Position | 73,425 | 74,663 | 68,040 | 72,640 | 76,963 |
| Net Cash Flow | $5,385 | $6,623 | $-17,361 | $-12,760 | $-8,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,641 | 343 | -3,794 | -3,505 | -2,964 |
| Free Cash Flow | -1,641 | 343 | -3,794 | -3,505 | -2,964 |